Contributed by Michael D. Cahalan, March 27, 2012 (sent for review January 27, 2012) B-cell-induced peripheral T-cell tolerance is characterized by suppression of T-cell proliferation and T-cell-dependent antibody production. However, the cellular interactions that underlie tolerance induction have not been identified. Using two-photon microscopy of lymph nodes we show that tolerogenic LPS-activated membranebound ovalbumin (mOVA) B cells (LPS B cells) establish long-lived, highly motile conjugate pairs with responding antigen-specific OTII T cells but not with antigen-irrelevant T cells. Treatment with anti-CTLA-4 disrupts persistent B-cell-T-cell (B-T) contacts and suppresses antigen-specific tolerance. Nontolerogenic CpG-activated mOVA B cells (CpG B cells) also form prolonged, motile conjugates with responding OTII T cells when transferred separately. However, when both tolerogenic and nontolerogenic B-cell populations are present, LPS B cells suppress long-lived CpG B-OTII T-cell interactions and exhibit tolerogenic dominance. Contact of LPS B cells with previously established B-T pairs resulted in partner-swapping events in which LPS B cells preferentially migrate toward and disrupt nontolerogenic CpG mOVA B-cell-OTII T-cell pairs. Our results demonstrate that establishment of peripheral T-cell tolerance involves physical engagement of B cells with the responding T-cell population, acting in a directed and competitive manner to alter the functional outcome of B-T interactions.
immunoimaging | lymph node B -cell presentation of antigen to CD4 + T cells can induce either T-cell priming or the establishment of long-lived antigenspecific tolerance characterized by reduced T-cell activation and effector responses (1) (2) (3) (4) (5) . Although interactions of early B-cell-CD4 + T-cell priming events have been visualized (5) , the dynamics of B-cell-T-cell (B-T) interactions that lead to long-lived peripheral tolerance remain uncharacterized. The expression of membrane-bound ovalbumin (mOVA) as a model antigen is a well-established approach for examining cell-specific immune responses and induction of tolerance to self-antigen (6) (7) (8) . Here, using B cells that express mOVA (hereafter, "mOVA B cells") as a self-antigen and ovalbumin-specific CD4 + OTII T cells as autoreactive T cells, we characterized tolerogenic B-T interactions and examined the dynamics of B-cell competition for antigenspecific T cells by two-photon microscopy in lymph node explants.
B cells have been investigated widely as antigen-presenting cells for the induction of therapeutic tolerance (9, 10) . The induction of tolerance by B cells expressing IgG linked to a target peptide has revealed long-term protective effects in several models of autoimmune disease, including type 1 diabetes, experimental autoimmune encephalomyelitis, experimental autoimmune uveitis, and formation of hemophilia inhibitors (11) (12) (13) (14) . B-cell-mediated long-lived tolerance in vivo is generated by the presentation of endogenously expressed antigen in the context of MHC class II via an IFN-γ-inducible lysosomal thiol reductase-dependent pathway and is CTLA-4 dependent (15) . Our study builds on previous investigations of tolerance induction in which adoptive transfer of LPS-activated B cells expressing antigen (hereafter, "LPS B cells") led to tolerance and to suppression of experimental autoimmune encephalomyelitis, whereas transfer of B cells activated by unmethylated CpG oligonucleotide (hereafter "CpG B cells") did not (10, 11, 16) .
Activation of B cells by Toll-like receptor (TLR) agonists modulates B cell maturation and alters T-cell-dependent B-cell responses to cognate antigen. The modulation of immune responses by TLR-activated B cells likely results because different TLR agonists induce varying expression patterns of chemokine receptors and molecules crucial for homing, antigen presentation, and formation of the immune synapse (17) (18) (19) . TLR4 activation by LPS treatment induces maturation of naive B cells and is implicated in the development of B-cell-driven lupus-like autoimmune disease (20, 21) . However, LPS-induced maturation of B cells can be redirected by B-cell receptor cross-linking toward a tolerogenic phenotype, demonstrating that tolerogenic B cells can be induced by TLR4 activation (21) . In contrast, the TLR9 agonist CpG is reported to play a role in the breaking of immune tolerance (22) .
Previous two-photon imaging studies have revealed that exogenously supplied antigen can trigger the formation of B-T conjugate pairs within the lymph node. Introduction of soluble antigen in vivo induces naive antigen-specific B cells to migrate toward the follicle boundary, where they form long-lasting B-T conjugate pairs with antigen-specific T cells, leading to robust T-cell-dependent B-cell antibody production (5) . In another study, ex vivo peptide-pulsed naive B cells transferred into a recipient induced tolerance and Tcell-associated transferable immunosuppression in a contact-dependent manner (4, 23) . Here, we examined the nature of B-T interactions after TLR4 or TLR9 activation of mOVA B cells presenting antigenic peptides to naive antigen-specific T cells. We used this model to define the behavior of tolerogenic (TLR4 activated by LPS) and nontolerogenic (TLR9 activated by CpG) B cells relative to naive antigen-specific T cells and found that competition between B cells is apparent at early time points during the induction of tolerance. Moreover, we observe that LPS-activated mOVA B cells (hereafter, "LPS mOVA B cells") physically disrupt nontolerogenic CpG B-cell-T-cell pairs, a mode of cellular interaction that may underlie the establishment of tolerogenic dominance.
Results
Naive and LPS-Treated B Cells Are Tolerogenic Antigen-Presenting Cells. Using transgenic mOVA mice, which express ovalbumin peptides (pOVA) in both MHC class I and class II (7), we investigated the capacity of naive LPS mOVA B cells and CpGactivated mOVA B cells (hereafter "CpG mOVA B cells") to establish tolerance. T cells recovered from recipients of naive or LPS mOVA B cells exhibited reduced CD4 T-cell proliferation upon challenge with the MHC class II OVA peptide 323-339 relative to T cells from animals that received unstimulated or LPStreated WT B cells ( Fig. 1 A and B) . T cells from animals that received CpG mOVA B cells showed proliferation kinetics similar to those of T cells from recipients of WT B cells (Fig. 1C) , whereas recipients of unstimulated or LPS mOVA B cells had suppressed antibody production relative to recipients of WT or CpG mOVA B cells (Fig. 1D ). In addition, CD4 + T cells recovered from recipients of LPS mOVA B cells showed significantly reduced IFN-γ production in vitro ( Fig. 1 E and F) . Finally, we investigated the capacity of mOVA B cells to induce tolerance in OVA-specific CD4 + OTII T cells. Adoptive transfer of LPS mOVA B cells led to a significant reduction in OTII T-cell proliferation upon secondary antigen challenge in vitro (Fig. 1G) . In contrast, CpG mOVA B cells failed to suppress T-cell proliferation (Fig. 1H) ), and B-T interactions were imaged in the B-cell follicle 18 h after T-cell transfer (Fig. S1A) . We tracked B cells in follicles as they migrated independently or as conjugate pairs of B and T cells (B-T pairs). LPS and CpG B cells migrated independently with average velocities of 8.2 ± 0.2 and 7.8 ± 0.2 μm/ min, respectively (mean ± SE of three separate experiments, P = 0.03). Motile B-T pairs, characterized by the B cell actively leading a single attached T cell, were found within follicles but not in the T zone in both LPS and CpG mOVA B-cell experiments ( Fig. 2 A-D) . LPS and CpG B-T pairs migrated with instantaneous velocities that were significantly slower than those of individual B cells (4.4 ± 0.1 μm/min for LPS B-T pairs, P < 0.001 relative to LPS B cells alone; and 5.3 ± 0.1 μm/min for CpG B-T pairs, P < 0.001 relative to CpG B cells alone) (Fig. 2E) . In both cases, motile B-T pairs were remarkably stable, some contacts lasting >1 h (Fig. 2 F and G) . B-T pairs remained coupled an average of 20.1 ± 2.9 min and 20.8 ± 2.4 min for LPS and CpG B-T pairs, respectively. Because it was not possible to visualize all B-T pairs from their formation to separation, the measured average contact duration represents an underestimate. We conclude that, despite the differences in functional outcomes when transferred separately, both tolerogenic LPS and nontolerogenic CpG mOVA B cells are capable of forming B-cell-OTII T-cell conjugate pairs that migrate with indistinguishable dynamics.
Naive mOVA B cells also induced long-lived peripheral tolerance ( Fig. 1 A and B) . Eighteen hours after T-cell adoptive transfer, naive mOVA B cells showed a slight but statistically significant increase in the duration of contact with cognate OTII T cells compared with the duration of contact between OTII T cells and naive WT B cells (Fig. 3A and B) . After 72 h, naive mOVA B cells formed stable B-T conjugate pairs with cognate T cells that occasionally lasted >40 min (Fig. 3 C and D; and Movie S3). Thus, despite a notable delay in the formation of conjugate pairs, the behavior of naive mOVA B-OTII T-cell was indistinguishable from that of other conjugate pairs in terms of contact duration and velocity. T-cell antigen specificity is important in other models of B-T conjugate pair formation (5) . As an additional control, we examined LPS and CpG WT B cells and found only short-lived interactions with WT T cells ( Fig. 3 E and F). We conclude that conjugate pairs form only when both B and T cells are antigen specific.
CTLA-4 Is Required for B-Cell-Induced Tolerance and for Long-Lived B-T Conjugates. CTLA-4 is necessary for the establishment of peripheral tolerance by B cells (25) . However, it is unknown if CTLA-4 is required for the formation of long-lived tolerogenic B-T conjugate pairs. To confirm a role for CTLA-4 in tolerance induction in our model, LPS-mOVA or WT donor B cells were adoptively transferred, followed 12 h later by OTII T cells, and recipient animals received either anti-CTLA-4 or isotype control antibody by two i.p. injections, 30 min and 12 h after T-cell transfer (Fig. S1B) . Measurements of recovered OTII T cells in response to challenge with pOVA demonstrated that treatment with anti-CTLA-4 at an early time point resulted in both enhanced IFN-γ production and in vivo proliferation (Fig. 4 A and  B and Fig. S2 ). In addition, treatment with anti-CTLA-4 blocking antibody significantly reduced LPS mOVA B-cell-OTII T-cell interactions relative to treatment with control antibody ( (Fig. 5D ). Adoptively transferred OTII T cells maintained normal T-cell velocities (averaging 12.4 μm/min) within the B-cell follicle, except during interaction with an LPS or CpG mOVA B cell, when velocities were reduced significantly (6.4 μm/min and 4.0 μm/min, respectively) (Fig. 5E ). Contact mapping of individual Tcell-contact histories further illustrates the preferential formation of long-lived LPS mOVA B-cell-OTII T-cell conjugate pairs in contrast to the brief CpG mOVA B-cell interactions (Fig. 5F ). These results indicate that, although both LPS and CpG mOVA B cells are capable of engaging OTII T cells (Fig. 2) , the presence of LPS mOVA B cells significantly inhibits the stability of contacts between CpG mOVA B cells and OTII T cells. As an additional test for antigen specificity, WT or OTII T cells were adoptively transferred 12 h after LPS and CpG mOVA B cells were cotransferred. Antigen-irrelevant WT T cells predominantly made short contacts and did not form conjugate pairs with either LPS or CpG mOVA B cells (Fig. 5G) (Fig.  5H) . Thus, cotransfer of LPS and CpG mOVA B cells led preferentially to the formation of B-T conjugate pairs between tolerogenic LPS B cells and antigen-specific T cells.
To assess the functional outcome of the cotransfer of CpG and LPS mOVA B cells, we performed in vitro assays of T-cell responses to pOVA following cotransfer and antigen challenge in vivo. LPS mOVA B cells established tolerance to self-antigen in vivo despite the presence of CpG mOVA B cells (Fig. S3 A-C) . Interestingly, at these early time points, LPS B cells were found in higher numbers than CpG B cells in the lymph node and tended to persist longer in the spleen over the course of several weeks ( Fig. S3 D and E) . The lower number of CpG B cells in the lymph node may result from shedding of CD62L after CpG activation of B cells (Fig. S3F) , a potential mechanism for redirecting B cells to the spleen (19) . LPS and CpG activation of mOVA B cells also altered the surface expression of CXCR5 and CCR7 relative to that in resting B cells (Fig. S3F ), but neither treatment altered B-cell localization within the lymph node as visualized by two-photon imaging and histological sections. In summary, LPS mOVA B cells out-compete CpG B cells and direct the functional outcome of the immune response. We also examined the expression of ligands known to play a role in tolerance and in the formation of B-T synapses (26) (27) (28) . LPS B cells expressed higher levels of B7.2 and intercellular adhesion molecule 1 (ICAM-1) than CpG B cells, both by FACS and mRNA analysis (Fig. S3 A and B) . In addition, we transduced LPS and CpG B cells with an IgG-tagged peptide (Eα) identifiable by FACS when presented in the context of MHC class II. Our results demonstrate that although MHC class II expression levels on CpG and LPS B cells are identical, LPS B cells present more endogenously expressed peptide in the context of MHC class II (Fig. S3 C  and D) . We suggest that the higher expression of B7.2, ICAM-1, and MHC class II peptide may contribute to the ability of LPS B cells to induce peripheral tolerance.
Visualizing Competition Between LPS and CpG mOVA B Cells for
Antigen-Specific T Cells. We then imaged partner-swapping interactions in which LPS mOVA B cells physically displaced CpG mOVA B cells from previously established OTII T-cell pairs (Fig.  S1D) . To clarify description, we refer to an existing B-T conjugate as "B1-T" and to the approaching B cell as "B2." LPS or CpG B cells that engaged in a three-way contact with an established B1-T pair usually interacted first with the already-paired B1 cell (79%; Fig. 6 A-C and Movie S7) before making contact with the target T cell to establish a transient three-way B2-T-B1 interaction. The threesome then resolved by partner exchange, leading to the formation of a long-lived LPS mOVA B2-T contact and leaving behind the original B1 cell. T-cell exchange between B cells was highly dynamic, and reciprocal swapping events sometimes occurred in <10 min (Fig. 6B and Movie S8).
Because CpG and LPS induce different levels of B-cell ligand expression, we analyzed key ligands known to play a role in B-T interactions (B7.2, ICAM-1, and self-peptide-MHC class II) (Fig. S4) . During partner exchange, three-way contacts typically were brief (4.6 ± 0.6 min) (Fig. 6D) . Surprisingly, although LPS mOVA B cells have higher ICAM-1 and B7.2 expression and self-peptide presentation, we found that the outcomes of threeway contacts (partner exchange, partner retention, or complete dissolution) were independent of whether an LPS or a CpG cell initiated contact; in both cases, partner retention was approximately threefold more likely than partner exchange (Fig. 6E) .
We then determined the relative number of three-way contacts initiated by LPS or CpG B cells. Because of the delayed adoptive transfer of LPS B cells, imaging frames typically showed greater numbers of individual CpG B cells and CpG-OTII conjugate pairs than LPS B cells. We thus normalized the number of contacts initiated by each B-cell type using a ratio of the total numbers of lone cells vs. target pairs within each imaging volume. When normalized in this way, LPS B cells initiated three-way contacts about six times more frequently than CpG mOVA B cells (Fig.  6F) ; without normalization, LPS B cells interacted with CpG Bcell-OTII T-cell pairs 2.5 times more frequently. LPS B-cell initiation of partner-swapping events is likely to contribute to the predominance of stable LPS mOVA B-cell-OTII T-cell pairs seen in cotransfer studies. On occasion, LPS mOVA B cells appeared to migrate from different points of origin as a swarm and to surround a CpG B-T pair ( To analyze further whether directed migration of B cells occurs in the proximity of B-T pairs, we developed a quantitative measure of directional persistence by calculating the 3D displacement of a B cell from its point of origin over the total distance traveled, in a step-wise manner (Fig. 7 A and B) . A value of 1 indicates straight-line motion away from the origin. We applied this analysis to control B cells migrating in the absence of OTII T cells (Fig. 7C) and to B cells 5-10 min before they contacted a B-T pair (Fig. 7D) . The mean directional persistence of interacting LPS B cells was significantly greater than for the control cells (0.45 ± 0.02 vs. 0.13 + 0.01; P < 0.001 in three separate experiments) and for all other B cells imaged (Fig. 7E) , indicating a directed approach of the LPS B cell toward the CpG B-T target. These results suggest that a local factor may induce B cells to migrate toward a B-T target and along straighter paths.
Discussion
Our results demonstrate that peripheral tolerance to self-antigen induced by B cells is an active, competitive process marked by the stable formation of conjugate pairs of B and T cells. Using mOVA Within the lymph node, we found that CpG and LPS B cells colocalized, suggesting that differential localization does not contribute to the contrasting functional outcomes. However, LPS B cells homed to lymph nodes more efficiently than CpG B cells and expressed significantly higher levels of CD62L, suggesting that preferential homing may serve as an additional factor to bias an immune response in favor of tolerogenic LPS B cells.
The importance of CTLA-4-based interactions for the maintenance of tolerance is evident in CTLA-4-knockout animals that develop lethal systemic autoimmune disease (29) . Here, we demonstrated that blocking CTLA-4 disrupted both B-T contacts and the establishment of peripheral tolerance, indicating that CTLA-4 stabilizes B-T interactions during induction of tolerance. Collectively, these results indicate that B-cell induction of peripheral tolerance to self-antigen is CTLA-4 dependent. CTLA-4-mediated suppression of an immune response occurs via both cell-intrinsic signaling and extrinsic contact-dependent transendocytosis of costimulatory molecules B7.1 and B7.2 (30). However, it was shown previously that B7-knockout B cells fail to induce tolerance, and expression of B7 costimulatory molecules by B cells is required for both naive T-cell activation and the maintenance of self-tolerance (31) (32) (33) . We found that LPS B cells expressed higher levels of B7.2 than CpG B cells but expressed similar levels of B7.1, indicating that induction of tolerance in this model is not the result of insufficient B7 costimulation. Thus, CTLA-4 engagement of B7 molecules appears necessary for the induction of tolerance and the stabilization of conjugate pairs.
In conclusion, our imaging results reveal a unique cellular choreography associated with the induction of B-cell tolerance, wherein B cells take on an active and competitive role. Although we do not rule out a role for cross-priming by dendritic cells, MHC class II expression on B cells is necessary for induction of T-cell tolerance (34) , and B-T interactions in vitro in the absence of dendritic cells are sufficient to induce T-cell tolerance (4), implying a direct role for B-cell presentation of antigen. LPS B-cell-induced T-cell tolerance requires CTLA-4 and the formation of antigen-dependent B-T conjugate pairs. Importantly, LPS B cells seek responding B-T conjugates and physically outcompete nontolerogenic B cells to alter the functional course of T-cell response to self-antigen.
Materials and Methods
Mice and Antigen. mOVA-expressing transgenic mice (Actb-OVA, stock number: 005145), OVA-specific OTII TCR transgenic mice, and C57BL/6J WT mice were purchased from the Jackson Laboratory. Animals were housed in pathogenfree microisolator cages, and all experiments were performed in accordance with a protocol approved by the Institutional Animal Care and Use Committees of the University of California, Irvine and the University of Maryland. pOVA p323-339 was purchased from Sigma-Aldrich.
Cells, Adoptive Transfer, and Analysis of Tolerance. T cells from OTII or WT mice and B cells from mOVA or WT mice were purified, labeled with green or red cell-tracker dyes, and transferred into WT C57BL6/J hosts. Homing, localization in lymph nodes, T-cell proliferation, T-cell-dependent antibody production, and gene expression responses were assessed as described in SI Materials and Methods.
Antibodies and Flow Cytometry. FITC anti-mouse CD19 (1D3), phycoerythrin anti-mouse CD62L (MEL-14), CD80 (16-10A1), CD86 (GL1), CD54 (3E2), CXCR5 (2G8), CCR7 (4B12), blocking CTLA-4 (UC10-4F10-11), and isotype control mAbs were purchased from Pharmingen and eBioscience. Methods for inhibition of tolerance by anti-CTLA-4 blocking antibody treatment in vivo and for flow cytometric analysis are described in SI Materials and Methods.
Two-Photon Imaging and Analysis. Two-photon imaging of excised peripheral lymph nodes was performed as described previously (35) and in SI Materials and Methods. Analysis was performed by a combination of automatic and manual tracking of individual cells.
Statistics. Data are presented as mean ± SEM. Normally distributed imaging data were analyzed using a two-tailed Student's t test. Significance of data sets containing an unmatched numbers of cells or nonnormally distributed data sets was determined using a Mann-Whitney u test. OriginPro 8 software (OrginLab) was used for all statistical analysis.
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